{"schema_version":"secwatch.filing_event.v1","accession":"0000915913-23-000164","form_type":"8-K","ticker":"ALB","cik":"0000915913","company_name":"ALBEMARLE CORP","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.015070+00:00","generated_at":"2026-06-12T16:10:01.649360+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Albemarle Q2 net sales +60% to $2.4B; adjusted EPS $7.33 vs $3.46 YoY","bullets":["Net sales $2.4B (+60% YoY); net income $650M ($5.52 diluted EPS).","Adjusted diluted EPS $7.33 (+112% YoY); adjusted EBITDA $1.0B (+69%).","Ford agreement to supply >100k metric tons lithium hydroxide from 2026-2030.","2023 guidance raised: net sales $10.4-$11.5B, adjusted EBITDA $3.8-$4.4B.","Capex raised to $1.9-$2.1B; net cash from ops lowered to $1.2-$1.8B due to DOJ/SEC settlements."],"urls":{"canonical":"https://secwatch.observer/filing/0000915913-23-000164","json":"https://secwatch.observer/filing/0000915913-23-000164.json","markdown":"https://secwatch.observer/filing/0000915913-23-000164.md","text":"https://secwatch.observer/filing/0000915913-23-000164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/915913/000091591323000164/0000915913-23-000164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/915913/000091591323000164/alb-20230802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T16:10:01.649360+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"15a06aec20136bd18d7faa1eb5feae8b1564a1e8","claim":"ALBEMARLE CORP reported the second quarter ended June 30, 2023 results: revenue $2.4 billion, net income $650.0 million, EPS $5.52 per diluted share.","evidence_excerpt":"Net sales of $2.4 billion, an increase of 60% • Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/915913/000091591323000164/0000915913-23-000164-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended June 30, 2023"},{"label":"Revenue","value":"$2.4 billion"},{"label":"Net income","value":"$650.0 million"},{"label":"EPS","value":"$5.52 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"3f1a2585011196dbd1ede84fb224eeeba86e1f8a","claim":"ALBEMARLE CORP reported full-year 2023 results: revenue $10.4 - $11.5 billion, EPS $25.00 - $29.50. Guidance raised.","evidence_excerpt":"FY 2023 Guidance as of August 2, 2023 Net sales $9.8 - $11.5 billion $10.4 - $11.5 billion Adjusted EBITDA (a) $3.3 - $4.0 billion $3.8 - $4.4 billion Adjusted EBITDA Margin (a) 34% - 35% 37% - 38% Adjusted Diluted EPS (a) $20.75 - $25.75 $25.00 - $29.50 Net Cash from Operations $1.7 - $2.3 billion $1.2 - $1.8 billion Capital Expenditures $1.7 - $1.9 billion $1.9 - $2.1 billion","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/915913/000091591323000164/0000915913-23-000164-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full-year 2023"},{"label":"Revenue","value":"$10.4 - $11.5 billion"},{"label":"EPS","value":"$25.00 - $29.50"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}